CAMBRIDGE, Mass. — Starting a biotech used to be simpler, conceptually speaking; some scientist with an idea would pitch it to people with money. After a dozen years — and as many lucky breaks — that scientist might have a successful company.
That doesn’t happen as much anymore. Some say that era is over.